Li Zhang

22PUBLICATIONS
44CO-AUTHORS
Molecular targetsPredictive and prognostic markersBiomaterialsLiquid biopsiesSensory systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Oct 13, 2026
Nanomedicines for prostate cancer therapy: stimuli-responsive design and disease-specific applications.

|Jun 03, 2026
CCT2 Promotes Prostate Cancer Progression Through EIF3F-Dependent Stabilization of FASN.

|Oct 23, 2025
Modulating Amyloid Pathology-Neural Hyperexcitability Crosstalk for Alzheimer's Disease Therapy.

Ying Wang, Jinfu Li, Ding Zhang

|Jun 29, 2025
Alcohol Intake-Induced Aggravation of Chronic Prostatitis/Chronic Pelvic Pain Syndrome is Associated with Reduced Gut Microbiota-Driven Short-Chain Fatty Acid Propionate and Butyrate.

Chang Liu, Shaoyu Yue, Di Niu

|Apr 22, 2024
MED15 is upregulated by HIF-2α and promotes proliferation and metastasis in clear cell renal cell carcinoma via activation of SREBP-dependent fatty acid synthesis.

Xiaoliang Hua, Shengdong Ge, Li Zhang

|Mar 06, 2024
Sodium butyrate alleviates experimental autoimmune prostatitis by inhibiting oxidative stress and NLRP3 inflammasome activation via the Nrf2/HO-1 pathway.

Xiaoliang Hua, Jiong Zhang, Juan Chen

Pageof 4

Frequent Collaborators

14 joint publications

Chaozhao Liang

4 joint publications

Ligang Zhang

4 joint publications

Jing Chen

4 joint publications

Meng Zhang